Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_assertion type Assertion NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_head.
- NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_assertion description "[Diabetic subjects with mutations in the gene encoding hepatocyte nuclear factor (HNF)-1alpha (MODY3) are prone to develop hypoglycaemia at low doses of glibenclamide, interpreted as sulphonylurea hypersensitivity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_provenance.
- NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_assertion evidence source_evidence_literature NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_provenance.
- NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_assertion SIO_000772 15787664 NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_provenance.
- NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_assertion wasDerivedFrom befree-20150227 NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_provenance.
- NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_assertion wasGeneratedBy ECO_0000203 NP724781.RAT1gSE_7SZrklTi3wQnhy2rffp8Aaa337LOJyQ9RYIfk130_provenance.